Dutch regulatory expresses concern that narrow-spectrum penicillin is no longer available
Astellas says phasing out is due to unavailability of excipients sodium citrate
These products will also be phased out of production in the coming years. Japanese pharma major Astellas (TYO: 4503) has informed the MEB that this is due to the fact that the excipient sodium citrate is no longer available.